Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Selective Adenosine 2a Antagonist to Enhance Training-related Gains in Walking Function for Persons With Chronic, Incomplete Spinal Cord Injury

NCT05217498 is registered in ClinicalTrials.gov with Randy Trumbower, PT, PhD as lead sponsor.

NCT NCT05217498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Selective Adenosine 2a Antagonist to Enhance Training-related Gains in Walking Function for Persons With Chronic, Incomplete Spinal Cord Injury
Lead sponsor
Randy Trumbower, PT, PhD
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 1, 2027
Completion date
June 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelopathy, spinal cord injuries